Baixinan (02185.HK) announced that investor Jiaxing Guojian Baixin Private Equity Investment Partnership has conditionally agreed to inject approximately 0.156 billion yuan (RMB, the same below) into Zhejiang Baixinan, of which about 37.88 million yuan will be listed as Zhejiang Baixinan's paid-in registered capital, while the remaining approximately 0.118 billion yuan will be listed as its capital reserve. The funds from the capital injection will be used as operating capital for Zhejiang Baixinan to develop its main Business.

Upon completion, the company's equity in Zhejiang Baixinan will be diluted from 100% to approximately 54.6792%, while the investor will hold 45.3208%.

Zhejiang Baixinan is primarily engaged in the production and commercialization of Innovative Medical Management medical instruments.